Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

75.68
Delayed Data
As of 3:54pm ET
 -0.0041 / -0.01%
Today’s Change
51.82
Today|||52-Week Range
77.12
+10.01%
Year-to-Date
Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2
12:21pm / Zacks.com - Paid Partner Content
'Mad Money' Lightning Round: Take Bristol-Myers Over Juno
Jul 20 / TheStreet.com - Paid Partner Content
Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?
9:29am / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Label Expansion Under U.S., EU Review
Jul 19 / Zacks.com - Paid Partner Content
Agenus (AGEN): What's Ahead for the Stock in Q2 Earnings?
9:29am / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Tagrisso Hits Phase III Primary Endpoint
Jul 19 / Zacks.com - Paid Partner Content
Bristol-Myers a Strong Biopharma Pick
3:02am / GuruFocus News - Paid Partner Content
What Awaits Boston Scientific (BSX) in Q2 Earnings?
Jul 19 / Zacks.com - Paid Partner Content
Barron's Picks And Pans: Pharmacy-Benefit Managers, Mortgage Insurers And More
Jul 24 / Benzinga - Paid Partner Content
Jim Cramer — J&J Is an Absolutely Terrific Stock
Jul 19 / TheStreet.com - Paid Partner Content
In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October
Jul 23 / MotleyFool.com - Paid Partner Content
J&J (JNJ) Stock Gains on Q2 Earnings and Improved Outlook
Jul 19 / Zacks.com - Paid Partner Content
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
5 Big Pharma Stocks Struggling to Raise Their Dividends
Jul 19 / MotleyFool.com - Paid Partner Content
Synta (SNTA) Cuts Q2 Loss Y/Y, Madrigal Merger in Focus
Jul 22 / Zacks.com - Paid Partner Content
Hologic (HOLX) Q3 Earnings: A Surprise in the Cards?
Jul 19 / Zacks.com - Paid Partner Content
Will Q2 Earnings Hold a Surprise for Nielsen (NLSN) Stock?
Jul 22 / Zacks.com - Paid Partner Content
Illumina (ILMN) to Report Q2 Earnings: What's in the Cards?
Jul 19 / Zacks.com - Paid Partner Content
Varian (VAR): What's in Store for the Stock in Q3 Earnings?
Jul 22 / Zacks.com - Paid Partner Content
Celgene to partner Jounce in battle against cancerous cells
Jul 19 / FT.com - Paid Partner Content
Gilead (GILD) Stock Likely to Beat This Earnings Season
Jul 21 / Zacks.com - Paid Partner Content
Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.
Jul 18 / Zacks.com - Paid Partner Content
Zimmer Biomet (ZBH) Q2 Earnings: A Beat in the Cards?
Jul 21 / Zacks.com - Paid Partner Content
Top 7 Research Reports for July 18, 2016
Jul 18 / Zacks.com - Paid Partner Content
GNC Holdings (GNC) Q2 Earnings: Will the Stock Disappoint?
Jul 21 / Zacks.com - Paid Partner Content
3 Stocks at 52-Week Highs Still Worth Buying
Jul 18 / MotleyFool.com - Paid Partner Content
Linear Technology (LLTC) Q4 Earnings: What's in the Cards?
Jul 21 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for July 18th
Jul 18 / Zacks.com - Paid Partner Content
13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys
Jul 21 / TheStreet.com - Paid Partner Content
3 Primary Ways Researchers Are Combatting Cancer
Jul 16 / MotleyFool.com - Paid Partner Content
ResMed (RMD) Q4 Earnings: Disappointment in the Cards?
Jul 20 / Zacks.com - Paid Partner Content
5 Things Celldex Therapeutics, Inc. Wants You to Know
Jul 13 / MotleyFool.com - Paid Partner Content
PayPal (PYPL) to Report Q2 Earnings: What's in the Cards?
Jul 20 / Zacks.com - Paid Partner Content
Bayer Expands Drug Discovery Collaboration with X-Chem
Jul 13 / Zacks.com - Paid Partner Content
5 Stocks to Buy and Hold for the Next Decade
Jul 20 / MotleyFool.com - Paid Partner Content
Top 7 Research Reports for July 13, 2016
Jul 13 / Zacks.com - Paid Partner Content
What's in Store for Mead Johnson (MJN) in Q2 Earnings?
Jul 20 / Zacks.com - Paid Partner Content